SPOTLIGHT: India to convert sites into drug labs


After shuttering three of its oldest vaccine manufacturing facilities for failing to abide by good manufacturing practices, Indian officials have named an expert panel to convert the plants into drug testing laboratories. In addition to safety and efficacy trials, the labs will also be responsible for identifying counterfeit drugs. Drug regulatory officials from WHO and Canada will be brought in to advise the panel in the best way to structure the new labs. Article